Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from ...

ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...

18, 2025 — New research suggests that decreased activity of ELOVL2 -- a key enzyme in lipid metabolism -- accelerates white blood cell aging and ... Regions of the Human Genome Apr.

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally ...

Agenus Inc. , a leader in immuno-oncology, today announced three upcoming presentations at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 ? June 3 in Chicago ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

AP Biosciences doses first patient in phase 1 clinical study to evaluate AP402 for HER2+ cancer patients: Taipei City, Taiwan Thursday, April 24, 2025, 18:00 Hrs [IST] AP Bioscien ...

Debiopharm announces oral and poster presentations on data from their potential first-in-class compound Debio 1562M, a ...

Kim Phillips-Fein, Robert Gardiner-Kenneth T. Jackson Professor of History, has won the 2025 Fiorello LaGuardia Book Prize ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with ...

Researchers at the Mount Sinai Health System will present groundbreaking science at the American Association for Cancer ...